Profile for Menlo Therapeutics Inc. (MNLO)

$ 5.32   0.08 (+1.53%) Volume: 26.23k 4:00 PM EDT Sep 13, 2019
After Hours:  $ 5.32 0.00 (0.00%) Volume: 212 4:00 PM EDT Sep 13, 2019
Business Description:
Menlo Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
Address: 200 Cardinal Way, 2nd Floor, Redwood City, CA, USA, 94063
Telephone: +1 650 486-1416 Website:
Facsimile: N/A Email: [email protected]
CEO: Steven L. Basta
Employees: 43 Market Cap: 127.43m
Issue Type: CS
Auditor: Mayer Hoffman McCann P.C.
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 1566044
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)